Stock Rich List
Nasdaq: SYRE

Spyre Therapeutics insiders

The officers, directors and 10% owners of Spyre Therapeutics, Inc. who hold the most stock, valued at the live SYRE price.

$97.63
SYRE today −$3.8M (−3.77%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
4
Their SYRE stock
$67.3M
Market value
$9.27B
Held by ranked insiders
0.73%

Insiders by value of SYRE holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1Cameron TurtleChief Executive Officer537,540$52.5M0.57%2428th
2Scott L. BurrowsChief Financial Officer79,762$7.8M<0.1%9209th
3Michael Thomas HendersonDirector68,606$6.7M<0.1%11773rd
4Marcio SouzaDirector3,600$351K<0.1%5468th

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Spyre Therapeutics; see each profile for the filing.